Olufisayo Elugbadebo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Olufisayo Elugbadebo has a total of 239 co-authors. Here are the top co-authors by number of shared publications:
Andrea Cipriani
Department of Psychiatry Oxford University of Oxford
10 shared publications- Claire Friedrich
Department of Psychiatry Oxford University of Oxford
10 shared publications Georgia Salanti
Institute of Social and Preventive Medicine Bern University of Bern
10 shared publications- James Thomas
EPPI-Centre, UCL Social Research Institute, University College London, Gower St, London, WC1E 6BT, UK
10 shared publications Jennifer Potts
Department of Psychiatry Oxford University of Oxford
10 shared publications- Simonne Wright
South Africa PTSD Research Programme of Excellence, Department of Psychiatry, Faculty of Medicine & Health Sciences, Stellenbosch University, Cape Town, South Africa
10 shared publications
Latest Publications
- Open Access
Sustained Viral Suppression and its association with Psychiatric Morbidity and Sleep Quality among Older Adults with Human Immunodeficiency Virus: Evidence from a Retrospective Cohort in Ibadan, Nigeria
Purpose: Older adults with HIV are at risk of psychiatric disorders and poor sleep quality, but evidence from sub-Saharan Africa is limited, particularly regarding sustained viral suppression. This study examined the prevalence of psychiatric disorders and poor sleep quality symptoms and their association with sustained viral suppression among older adults with HIV in Nigeria. Methods: A retrospective cohort study was conducted among older adults receiving care at a tertiary HIV clinic in Ibadan, Nigeria. Viral load data from 2019-2023 were abstracted from medical records to determine sustained viral load suppression, while psychiatric morbidity and sleep quality were assessed cross-sectionally in 2023. Psychiatric morbidity, including major depressive disorder, anxiety disorder, bipolar disorder and mania, was assessed using the World Mental Health Composite International Diagnostic Interview (WMH-CIDI), while sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI). Mixed-effects logistic regression assessed changes in viral suppression over time and associations with psychiatric morbidity and sleep quality. Results: Among 400 participants, 63.5% were female and mean age was 58.2 years (± 6.5). The 12-month prevalence of major depressive disorder was 25.8% while 17.5% had anxiety disorder, 29.3% had poor sleep quality, 3.3%, bipolar disorder, and 1.0% mania. Viral suppression improved significantly over the retrospective period. Sustained viral suppression was significantly associated with higher odds of good sleep quality (OR = 1.69, 95% CI: 1.07–2.66, p = 0.025), but not psychiatric morbidity. Conclusion: Psychiatric disorders and poor sleep quality are common among older adults with HIV in Nigeria. Sustained viral suppression was associated with better sleep quality but not psychiatric morbidity highlighting the importance of integrating mental health and sleep assessment into comprehensive HIV care for older adults.
Open AccessSustained Viral Suppression and its association with Psychiatric Morbidity and Sleep Quality among Older Adults with Human Immunodeficiency Virus: Evidence from a Retrospective Cohort in Ibadan, Nigeria
Purpose: Older adults with HIV are at risk of psychiatric disorders and poor sleep quality, but evidence from sub-Saharan Africa is limited, particularly regarding sustained viral suppression. This study examined the prevalence of psychiatric disorders and poor sleep quality symptoms and their association with sustained viral suppression among older adults with HIV in Nigeria. Methods: A retrospective cohort study was conducted among older adults receiving care at a tertiary HIV clinic in Ibadan, Nigeria. Viral load data from 2019-2023 were abstracted from medical records to determine sustained viral load suppression, while psychiatric morbidity and sleep quality were assessed cross-sectionally in 2023. Psychiatric morbidity, including major depressive disorder, anxiety disorder, bipolar disorder and mania, was assessed using the World Mental Health Composite International Diagnostic Interview (WMH-CIDI), while sleep quality was assessed using the Pittsburgh Sleep Quality Index (PSQI). Mixed-effects logistic regression assessed changes in viral suppression over time and associations with psychiatric morbidity and sleep quality. Results: Among 400 participants, 63.5% were female and mean age was 58.2 years (± 6.5). The 12-month prevalence of major depressive disorder was 25.8% while 17.5% had anxiety disorder, 29.3% had poor sleep quality, 3.3%, bipolar disorder, and 1.0% mania. Viral suppression improved significantly over the retrospective period. Sustained viral suppression was significantly associated with higher odds of good sleep quality (OR = 1.69, 95% CI: 1.07–2.66, p = 0.025), but not psychiatric morbidity. Conclusion: Psychiatric disorders and poor sleep quality are common among older adults with HIV in Nigeria. Sustained viral suppression was associated with better sleep quality but not psychiatric morbidity highlighting the importance of integrating mental health and sleep assessment into comprehensive HIV care for older adults.
- Open Access
- 8 October 2026
- Published by Springer Nature in Research Square
The Association of Resilience with Psychiatric Morbidity, Sleep Quality and Antiretroviral Therapy Adherence among Older Adults Living with HIV in Nigeria
Advances in antiretroviral therapy (ART) have increased survival among people living with HIV, resulting in a growing population of older adults who often face persistent psychological challenges. However, limited evidence exists on how in the face of these challenges, resilience may interact with psychiatric morbidity and HIV treatment adherence in African countries. This study therefore examined resilience among older adults living with HIV in Ibadan, Nigeria and its association with psychiatric morbidity and ART adherence. In this cross-sectional study, resilience, psychiatric morbidity and HIV treatment adherence were assessed among 400 older adults aged ≥ 50 years living with HIV. Resilience, depression, anxiety and sleep quality were measured using the 25-item Wagnild and Young resilience scale, Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder 7-item scale (GAD-7) and the Pittsburgh Sleep Quality Index (PSQI) respectively. Antiretroviral medication adherence was self-reported for the prior 30-days. Associations between resilience levels, psychiatric morbidity, and medication adherence outcomes were investigated using multivariable logistic regression controlling for demographic and clinical factors. The mean age of participants was 58.2 ± 6.5 years. Low resilience was common, affecting approximately 89.7% of the cohort. The prevalence of psychiatric morbidity was 7.8% for depression, 6.0% for anxiety, and 15.2% for poor sleep quality. Overall, ART adherence was relatively high, with 85.5% of participants reporting adequate adherence. Higher resilience scores were associated with lower odds of depression (adjusted [aOR] = 0.958, 95% CI: 0.939–0.977), anxiety (aOR = 0.971, 95% CI: 0.950–0.993, p = 0.010) and an increased odds of at least 95% antiretroviral therapy adherence (aOR = 1.033, 95% CI: 1.008–1.058, p = 0.009). In this study of older adults living with HIV in Nigeria, the level of resilience was low but was protective for psychiatric morbidity and medication adherence. Promoting resilience may improve well-being among aging populations living with HIV.
- 8 October 2026
- Published by Springer Nature in Research Square
Open AccessThe Association of Resilience with Psychiatric Morbidity, Sleep Quality and Antiretroviral Therapy Adherence among Older Adults Living with HIV in Nigeria
Advances in antiretroviral therapy (ART) have increased survival among people living with HIV, resulting in a growing population of older adults who often face persistent psychological challenges. However, limited evidence exists on how in the face of these challenges, resilience may interact with psychiatric morbidity and HIV treatment adherence in African countries. This study therefore examined resilience among older adults living with HIV in Ibadan, Nigeria and its association with psychiatric morbidity and ART adherence. In this cross-sectional study, resilience, psychiatric morbidity and HIV treatment adherence were assessed among 400 older adults aged ≥ 50 years living with HIV. Resilience, depression, anxiety and sleep quality were measured using the 25-item Wagnild and Young resilience scale, Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder 7-item scale (GAD-7) and the Pittsburgh Sleep Quality Index (PSQI) respectively. Antiretroviral medication adherence was self-reported for the prior 30-days. Associations between resilience levels, psychiatric morbidity, and medication adherence outcomes were investigated using multivariable logistic regression controlling for demographic and clinical factors. The mean age of participants was 58.2 ± 6.5 years. Low resilience was common, affecting approximately 89.7% of the cohort. The prevalence of psychiatric morbidity was 7.8% for depression, 6.0% for anxiety, and 15.2% for poor sleep quality. Overall, ART adherence was relatively high, with 85.5% of participants reporting adequate adherence. Higher resilience scores were associated with lower odds of depression (adjusted [aOR] = 0.958, 95% CI: 0.939–0.977), anxiety (aOR = 0.971, 95% CI: 0.950–0.993, p = 0.010) and an increased odds of at least 95% antiretroviral therapy adherence (aOR = 1.033, 95% CI: 1.008–1.058, p = 0.009). In this study of older adults living with HIV in Nigeria, the level of resilience was low but was protective for psychiatric morbidity and medication adherence. Promoting resilience may improve well-being among aging populations living with HIV.
- Open Access
- 26 June 2026
- Published by Brain Health Literacy Company Limited by Guarantee in Journal of Brain Health
- Vol. 1 (1)
Facilitators and Barriers to Engaging Families of Persons with Dementia in Research within Geriatric Clinics in Nigeria: Perspectives from Families
Introduction: Despite the central role of families in dementia caregiving, limited research has examined what shapes their willingness and ability to participate in dementia research. Objective(s): This study explored the relational, cultural, and structural factors influencing families’ engagement in research within a psychogeriatric clinic in Nigeria. Methods: We employed a narrative qualitative approach, recruiting 12 caregivers of people living with dementia from a Nigerian psychogeriatric clinic. Participants engaged in semi-structured interviews at their homes, providing rich reflections on their lived experiences, expectations, and perceptions of participating in dementia-related research. Data were subjected to thematic analysis to capture the nuanced meanings families attach to research participation within their sociocultural contexts. Results: Families described several facilitators to research participation, including access to healthcare, opportunities to gain dementia-related knowledge, trust in healthcare professionals, and material or financial support. Conversely, significant barriers included lengthy assessments, emotional exhaustion, limited communication of research findings, and uncertainty about the purpose of research. Therapeutic misconception such as the expectation that participation would directly improve the health of their relative influenced recruitment and retention. Families emphasized the importance of involving them and the person with dementia in every stage of study planning to enhance trust, relevance, ethical responsiveness, and cultural sensitivity. Discussion: Aligning research procedures with participant expectations, enhancing transparency and communication, addressing therapeutic misconception and undue inducement, and integrating families into the research process may strengthen recruitment, retention, and the broader social impact of dementia research in African settings.
- 26 June 2026
- Published by Brain Health Literacy Company Limited by Guarantee in Journal of Brain Health
- Vol. 1 (1)
Open AccessFacilitators and Barriers to Engaging Families of Persons with Dementia in Research within Geriatric Clinics in Nigeria: Perspectives from Families
Introduction: Despite the central role of families in dementia caregiving, limited research has examined what shapes their willingness and ability to participate in dementia research. Objective(s): This study explored the relational, cultural, and structural factors influencing families’ engagement in research within a psychogeriatric clinic in Nigeria. Methods: We employed a narrative qualitative approach, recruiting 12 caregivers of people living with dementia from a Nigerian psychogeriatric clinic. Participants engaged in semi-structured interviews at their homes, providing rich reflections on their lived experiences, expectations, and perceptions of participating in dementia-related research. Data were subjected to thematic analysis to capture the nuanced meanings families attach to research participation within their sociocultural contexts. Results: Families described several facilitators to research participation, including access to healthcare, opportunities to gain dementia-related knowledge, trust in healthcare professionals, and material or financial support. Conversely, significant barriers included lengthy assessments, emotional exhaustion, limited communication of research findings, and uncertainty about the purpose of research. Therapeutic misconception such as the expectation that participation would directly improve the health of their relative influenced recruitment and retention. Families emphasized the importance of involving them and the person with dementia in every stage of study planning to enhance trust, relevance, ethical responsiveness, and cultural sensitivity. Discussion: Aligning research procedures with participant expectations, enhancing transparency and communication, addressing therapeutic misconception and undue inducement, and integrating families into the research process may strengthen recruitment, retention, and the broader social impact of dementia research in African settings.
- Open Access
- 25 May 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 11, 154
Cognitive bias modification for social anxiety: a living systematic review and network meta-analysis
Background Cognitive Bias Modification (CBM) is a potentially effective intervention for social anxiety disorder (SAD). However, the relative efficacy of CBM subtypes remains uncertain. Methods We co-produced a living systematic review of controlled studies evaluating stand alone CBM in participants with SAD and in non-clinical participants undergoing a social stressor, seeking to triangulate these. Databases were searched until October 2025 and two independent reviewers screened, extracted and critically appraised studies. The primary outcome was reduction in SAD symptoms, but we collected data on other mental health outcomes. Random-effect network meta-analysis was conducted. Credibility was assessed using the Confidence In Network Meta-Analysis framework. Results CBM for attention (CBM-A) demonstrated the largest reduction in SAD symptoms relative to control CBM-A although this estimate was imprecise (Standardised Mean Difference (SMD) = −0.18, 95% CI: −0.41 to 0.05, 95% PI: −1.02 to 1.04). Opposite CBM-A, training attention towards negative stimuli, performed similarly (SMD -0.17, 95% CI: −0.65 to 0.31, 95% PI: −0.97 to 1.21). CBM for interpretation (CBM-I) reduced SAD symptoms (SMD = −0.47, 95% CI: −0.84 to −0.09, 95% PI: −0.53 to 1.46) and cognitive bias versus its task-matched control condition without active bias training. The SAD network showed high inconsistency and 95% of studies were at moderate or high risk of bias. Three comparisons involving CBM-A were rated as moderate confidence, all others were low or very low. Sparse data precluded NMA of outcomes in non-SAD participants. Conclusion Inconsistency and imprecision in the network preclude firm conclusions regarding CBM efficacy for SAD. CBM-A showed a small effect but its similarity to opposite CBM-A suggests benefits may not depend on training direction. Future studies should explore the mechanism of CBM and reporting on potential side-effects. We will update this living systematic review as part of the GALENOS project. Registration: PROSPERO-ID:CRD42024601380.
- 25 May 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 11, 154
Open AccessCognitive bias modification for social anxiety: a living systematic review and network meta-analysis
Background Cognitive Bias Modification (CBM) is a potentially effective intervention for social anxiety disorder (SAD). However, the relative efficacy of CBM subtypes remains uncertain. Methods We co-produced a living systematic review of controlled studies evaluating stand alone CBM in participants with SAD and in non-clinical participants undergoing a social stressor, seeking to triangulate these. Databases were searched until October 2025 and two independent reviewers screened, extracted and critically appraised studies. The primary outcome was reduction in SAD symptoms, but we collected data on other mental health outcomes. Random-effect network meta-analysis was conducted. Credibility was assessed using the Confidence In Network Meta-Analysis framework. Results CBM for attention (CBM-A) demonstrated the largest reduction in SAD symptoms relative to control CBM-A although this estimate was imprecise (Standardised Mean Difference (SMD) = −0.18, 95% CI: −0.41 to 0.05, 95% PI: −1.02 to 1.04). Opposite CBM-A, training attention towards negative stimuli, performed similarly (SMD -0.17, 95% CI: −0.65 to 0.31, 95% PI: −0.97 to 1.21). CBM for interpretation (CBM-I) reduced SAD symptoms (SMD = −0.47, 95% CI: −0.84 to −0.09, 95% PI: −0.53 to 1.46) and cognitive bias versus its task-matched control condition without active bias training. The SAD network showed high inconsistency and 95% of studies were at moderate or high risk of bias. Three comparisons involving CBM-A were rated as moderate confidence, all others were low or very low. Sparse data precluded NMA of outcomes in non-SAD participants. Conclusion Inconsistency and imprecision in the network preclude firm conclusions regarding CBM efficacy for SAD. CBM-A showed a small effect but its similarity to opposite CBM-A suggests benefits may not depend on training direction. Future studies should explore the mechanism of CBM and reporting on potential side-effects. We will update this living systematic review as part of the GALENOS project. Registration: PROSPERO-ID:CRD42024601380.
- Open Access
- 27 February 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 11, 154
Cognitive bias modification for social anxiety: a living systematic review and network meta-analysis
Background Cognitive Bias Modification (CBM) is a potentially effective intervention for social anxiety disorder (SAD). However, this has never been tested in a living systematic review and the relative efficacy of CBM subtypes remains uncertain. Methods We co-produced a living systematic review of controlled studies evaluating CBM in participants with SAD and in non-clinical participants undergoing a social stressor, seeking to triangulate these. Databases were searched until October 2025 and two independent reviewers screened, extracted and critically appraised studies. The primary outcome was reduction in SAD symptoms, but we collected data on other mental health outcomes. Random-effect network meta-analysis was conducted. Credibility was assessed using the Confidence In Network Meta-Analysis framework. Results CBM for attention (CBM-A) demonstrated the largest reduction in SAD symptoms relative to control CBM-A although this estimate was imprecise (Standardised Mean Difference (SMD) = -0.18, 95% CI: -0.41 to 0.05, 95% PI: -1.02 to 1.04). Opposite CBM-A, training attention towards negative stimuli, performed similarly (SMD -0.17, 95% CI: -0.65 to 0.31, 95% PI: -0.97 to 1.21). CBM for interpretation (CBM-I) reduced SAD symptoms (SMD = -0.47, 95% CI: -0.84 to -0.09, 95% PI: -0.53 to 1.46) and cognitive bias versus its structurally matched control. The SAD network showed high inconsistency and 95% of studies were at moderate or high risk of bias. Three comparisons involving CBM-A were rated as moderate confidence, all others were low or very low. Sparse data precluded NMA of outcomes in non-SAD participants. Conclusion Inconsistency and imprecision in the network preclude firm conclusions regarding CBM efficacy for SAD. CBM-A showed a small effect but its similarity to opposite CBM-A suggests benefits may not depend on training direction. Future studies should explore the mechanism of CBM and reporting on potential side-effects. We will update this review as part of the GALENOS project. Registration: PROSPERO-ID:CRD42024601380
- 27 February 2026
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 11, 154
Open AccessCognitive bias modification for social anxiety: a living systematic review and network meta-analysis
Background Cognitive Bias Modification (CBM) is a potentially effective intervention for social anxiety disorder (SAD). However, this has never been tested in a living systematic review and the relative efficacy of CBM subtypes remains uncertain. Methods We co-produced a living systematic review of controlled studies evaluating CBM in participants with SAD and in non-clinical participants undergoing a social stressor, seeking to triangulate these. Databases were searched until October 2025 and two independent reviewers screened, extracted and critically appraised studies. The primary outcome was reduction in SAD symptoms, but we collected data on other mental health outcomes. Random-effect network meta-analysis was conducted. Credibility was assessed using the Confidence In Network Meta-Analysis framework. Results CBM for attention (CBM-A) demonstrated the largest reduction in SAD symptoms relative to control CBM-A although this estimate was imprecise (Standardised Mean Difference (SMD) = -0.18, 95% CI: -0.41 to 0.05, 95% PI: -1.02 to 1.04). Opposite CBM-A, training attention towards negative stimuli, performed similarly (SMD -0.17, 95% CI: -0.65 to 0.31, 95% PI: -0.97 to 1.21). CBM for interpretation (CBM-I) reduced SAD symptoms (SMD = -0.47, 95% CI: -0.84 to -0.09, 95% PI: -0.53 to 1.46) and cognitive bias versus its structurally matched control. The SAD network showed high inconsistency and 95% of studies were at moderate or high risk of bias. Three comparisons involving CBM-A were rated as moderate confidence, all others were low or very low. Sparse data precluded NMA of outcomes in non-SAD participants. Conclusion Inconsistency and imprecision in the network preclude firm conclusions regarding CBM efficacy for SAD. CBM-A showed a small effect but its similarity to opposite CBM-A suggests benefits may not depend on training direction. Future studies should explore the mechanism of CBM and reporting on potential side-effects. We will update this review as part of the GALENOS project. Registration: PROSPERO-ID:CRD42024601380
- 9 February 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 110 (2) , 716-727
Recruiting and retaining persons with suspected Alzheimer's disease and related dementias for genetic studies in selected African countries: Lived realities of researchers
Background: Genomic research in dementia in Africa is of utmost importance based on recent reports from studies on African-Americans that the African ancestral gene is associated with a lower risk effect for developing AD. However, dementia-related genetic studies are still evolving in sub-Saharan Africa, with unique challenges influencing participant recruitment. Objective: This study sought to identify key challenges of recruitment and retention how they were mitigated in the READD-ADSP Africa and ‘Origins of AD in African ancestry’ genetic studies. Methods: A qualitative narrative research design using in-depth interviews explored the challenges of recruiting participants and how these were managed by the nineteen stakeholders involved in the recruitment process from nine African countries participating in the African Dementia Consortium. An inductive thematic analysis was applied to code and analyze the data systematically. Results: Nineteen stakeholders from nine African countries, participating in READD-ADSP and ‘Origins’ studies were interviewed. Similar challenges were observed across most African countries, including the non-existing national dementia registry. Other challenges include language diversity, myths around blood collection, family dynamics, stigma, logistics, unmet expectations concerning incentives, fewer older controls and data privacy. Leveraging previous research programs, existing community engagement activities and client-doctor relationships were strategies used in addressing these challenges. Conclusions: There are some unique challenges with recruiting and retaining participants in genetic studies in Africa. Strengthening community engagement and advocacy for genomic research, alongside a well-populated dementia registry in the African Dementia Consortium, could overcome these challenges and improve participant recruitment in genetic studies.
- 9 February 2026
- Published by SAGE Publications in Journal of Alzheimer’s Disease
- Vol. 110 (2) , 716-727
Recruiting and retaining persons with suspected Alzheimer's disease and related dementias for genetic studies in selected African countries: Lived realities of researchers
Background: Genomic research in dementia in Africa is of utmost importance based on recent reports from studies on African-Americans that the African ancestral gene is associated with a lower risk effect for developing AD. However, dementia-related genetic studies are still evolving in sub-Saharan Africa, with unique challenges influencing participant recruitment. Objective: This study sought to identify key challenges of recruitment and retention how they were mitigated in the READD-ADSP Africa and ‘Origins of AD in African ancestry’ genetic studies. Methods: A qualitative narrative research design using in-depth interviews explored the challenges of recruiting participants and how these were managed by the nineteen stakeholders involved in the recruitment process from nine African countries participating in the African Dementia Consortium. An inductive thematic analysis was applied to code and analyze the data systematically. Results: Nineteen stakeholders from nine African countries, participating in READD-ADSP and ‘Origins’ studies were interviewed. Similar challenges were observed across most African countries, including the non-existing national dementia registry. Other challenges include language diversity, myths around blood collection, family dynamics, stigma, logistics, unmet expectations concerning incentives, fewer older controls and data privacy. Leveraging previous research programs, existing community engagement activities and client-doctor relationships were strategies used in addressing these challenges. Conclusions: There are some unique challenges with recruiting and retaining participants in genetic studies in Africa. Strengthening community engagement and advocacy for genomic research, alongside a well-populated dementia registry in the African Dementia Consortium, could overcome these challenges and improve participant recruitment in genetic studies.
- Open Access
- 1 January 2026
- Published by Wiley in AIDS Research and Treatment
- Vol. 2026 (1) , 9573277
Rapid Qualitative Analysis to Inform Preimplementation of a Stepped‐Care Model for Depression Care Among Older People Living With HIV in Ibadan, Nigeria
Background: Depression is common among older adults living with HIV (OLHIV) and is associated with poor antiretroviral adherence and higher viral load. Despite the importance of addressing psychological health issues in older people living with HIV, there is a paucity of tailored depression interventions for low‐resource settings. Although the stepped‐care task‐sharing (SCT) intervention model is effective for depression in low‐resource settings, it has not been applied to this population. This study examined preimplementation requirements for piloting a SCT model for depression among OLHIV in a government‐funded clinic in Southwest Nigeria. Methods: We conducted a qualitative preimplementation study, guided by the Consolidated Framework for Implementation Research (CFIR), to assess the contextual fit and feasibility of integrating a SCT intervention for depression into routine HIV services. In‐depth interviews were conducted with healthcare providers and older adults with HIV at the Infectious Disease Institute, Ibadan, Nigeria. Data were analyzed using rapid qualitative methods to identify CFIR‐informed barriers, facilitators, and adaptation needs to guide intervention refinement prior to pilot testing. Results: Twenty‐two interviews were conducted with healthcare providers ( n = 11) and OLHIV ( n = 11), each lasting 30–45 min. Findings indicated that the SCT intervention was perceived as feasible, supported by staff willingness and existing clinic structures that could be leveraged during pilot testing. Key barriers to implementation included high workload, limited provider training, stigma, discontinuity of care, and financial constraints. Facilitators included organizational readiness and high acceptability among service users. Conclusion: The SCT model is perceived as acceptable and potentially feasible for integrating depression care into HIV services for OLHIV. However, it requires adaptation into existing workflows, provider capacity, and patient follow‐up routines. Findings provide insights to refine the intervention processes in preparation for pilot testing and integration of psychological healthcare into HIV services.
- 1 January 2026
- Published by Wiley in AIDS Research and Treatment
- Vol. 2026 (1) , 9573277
Open AccessRapid Qualitative Analysis to Inform Preimplementation of a Stepped‐Care Model for Depression Care Among Older People Living With HIV in Ibadan, Nigeria
Background: Depression is common among older adults living with HIV (OLHIV) and is associated with poor antiretroviral adherence and higher viral load. Despite the importance of addressing psychological health issues in older people living with HIV, there is a paucity of tailored depression interventions for low‐resource settings. Although the stepped‐care task‐sharing (SCT) intervention model is effective for depression in low‐resource settings, it has not been applied to this population. This study examined preimplementation requirements for piloting a SCT model for depression among OLHIV in a government‐funded clinic in Southwest Nigeria. Methods: We conducted a qualitative preimplementation study, guided by the Consolidated Framework for Implementation Research (CFIR), to assess the contextual fit and feasibility of integrating a SCT intervention for depression into routine HIV services. In‐depth interviews were conducted with healthcare providers and older adults with HIV at the Infectious Disease Institute, Ibadan, Nigeria. Data were analyzed using rapid qualitative methods to identify CFIR‐informed barriers, facilitators, and adaptation needs to guide intervention refinement prior to pilot testing. Results: Twenty‐two interviews were conducted with healthcare providers ( n = 11) and OLHIV ( n = 11), each lasting 30–45 min. Findings indicated that the SCT intervention was perceived as feasible, supported by staff willingness and existing clinic structures that could be leveraged during pilot testing. Key barriers to implementation included high workload, limited provider training, stigma, discontinuity of care, and financial constraints. Facilitators included organizational readiness and high acceptability among service users. Conclusion: The SCT model is perceived as acceptable and potentially feasible for integrating depression care into HIV services for OLHIV. However, it requires adaptation into existing workflows, provider capacity, and patient follow‐up routines. Findings provide insights to refine the intervention processes in preparation for pilot testing and integration of psychological healthcare into HIV services.
- Open Access
- 1 January 2026
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 17 (1)
Evaluation of perception towards brain health in Nigeria: Results from a nationwide awareness survey
Background: Brain health involves the continuous functioning of mental, cognitive, motor and physical abilities driven by brain processes. Despite high levels of brain health risk in Nigeria, there is a lack of data on the public perception of brain health. Aim: The authors investigated the perception of brain health and explored the interplay between demographic factors and brain health awareness. Setting: The research was carried out among the Nigerian population. Methods: A total of 570 participants responded to a cross-sectional survey conducted using Google Form link shared through WhatsApp and Facebook and convenience sampling between April 2023 and August 2023. Brain health perceptions were assessed across key domains. Statistical Package for Social Sciences version 29.0 was used for analysis. Bivariate correlations and logistic regression explored the relationships between socio-demographics and brain health perception. Results: Substance use was rated by 67% of participants as influencing factor for brain health. All life stages were considered important for brain care. Men were less likely than women to attribute family income, substance use and sleep as key influences. Remarkably, only 43.9%, 19.5% and 19.5% of participants agreed that an association exists between hypertension, diabetes and arthritis with brain health. Conclusion: The study’s findings suggest that there are notable gaps and gender differences in perceptions, underscoring the need for targeted health education. Addressing these gaps could improve the understanding of factors influencing brain health and support policy efforts in Nigeria. Contribution: This study provides unique insight into the gaps in the public perception of brain health in Nigeria, serving as a baseline study for future research.
- 1 January 2026
- Published by AOSIS in Journal of Public Health in Africa
- Vol. 17 (1)
Open AccessEvaluation of perception towards brain health in Nigeria: Results from a nationwide awareness survey
Background: Brain health involves the continuous functioning of mental, cognitive, motor and physical abilities driven by brain processes. Despite high levels of brain health risk in Nigeria, there is a lack of data on the public perception of brain health. Aim: The authors investigated the perception of brain health and explored the interplay between demographic factors and brain health awareness. Setting: The research was carried out among the Nigerian population. Methods: A total of 570 participants responded to a cross-sectional survey conducted using Google Form link shared through WhatsApp and Facebook and convenience sampling between April 2023 and August 2023. Brain health perceptions were assessed across key domains. Statistical Package for Social Sciences version 29.0 was used for analysis. Bivariate correlations and logistic regression explored the relationships between socio-demographics and brain health perception. Results: Substance use was rated by 67% of participants as influencing factor for brain health. All life stages were considered important for brain care. Men were less likely than women to attribute family income, substance use and sleep as key influences. Remarkably, only 43.9%, 19.5% and 19.5% of participants agreed that an association exists between hypertension, diabetes and arthritis with brain health. Conclusion: The study’s findings suggest that there are notable gaps and gender differences in perceptions, underscoring the need for targeted health education. Addressing these gaps could improve the understanding of factors influencing brain health and support policy efforts in Nigeria. Contribution: This study provides unique insight into the gaps in the public perception of brain health in Nigeria, serving as a baseline study for future research.
- Open Access
- 26 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S3) , e106579
Behavioral and Psychological Symptoms of Dementia as a Clinical Indicator of Disease Severity and Memory Decline in African Populations: Data from the READD–ADSP Project
Background: BPSD are common in persons living with dementia and are often associated with disease severity and caregivers’ distress. In Low‐ and Middle‐Income Countries, they are often the symptom complex that compel family to seek medical help. However, the association of BPSD with dementia severity and specific cognitive domains is underexplored in African populations. This study aims to evaluate BPSD among indigenous Africans and the association with specific cognitive domains. Method: This cross‐sectional study analyzes data collected from nine African countries (Nigeria, Benin, Ghana, Cameroon, Ethiopia, Kenya, Uganda, Tanzania, and Mozambique) participating in the Recruitment and Retention for Alzheimer's Disease Diversity Cohorts in the Alzheimer's Disease Sequencing Project (READD‐ADSP) project, from June 2023 to December 2024. Data on neurocognitive factors were collected using the Uniform Data Set (UDS), Neuropsychiatric Inventory Questionnaire (NPI‐Q) for BPSD, and the Clinical Dementia Rating (CDR) scale for dementia severity. Data was managed on REDCap and analysis was performed using STATA (v16). Descriptive statistics were employed for symptom prevalence, and Spearman's rank correlation was used to analyze the relationship between NPI‐Q and CDR scores. Association between cognitive domains and behavioral symptoms was examined using hierarchical linear model adjusting for covariates such as age, gender, education, and illness duration. Result: A total of 641 Africans with dementia (61% female, mean age 76.7±10.1 years) were included. The mean (±SD) NPI and CDR scores were 4.91 (±6.25) and 1.84 (±1.25), respectively. The most prevalent BPSD symptoms were apathy (32%), agitation/aggression (28.7%), and depression (28.1%). Spearman's correlation revealed a weak but significant positive association between NPI‐Q severity scores and CDR scores (rho = 0.264, p < 0.001). Behavioral symptoms were significantly associated with dementia severity (β = 1.59, CI: 1.15–2.03) as well as specific cognitive domains, particularly memory (digit span backward: β = ‐0.38, CI: ‐0.64 to ‐0.13). However, the duration of illness was not a significant predictor of behavioral symptoms in this cohort. Conclusion: The findings suggest that BPSD are both an indicator and consequence of dementia severity, particularly in memory function. This study posits the need for targeted management of BPSD and improvement in overall patient care in LMICs
- 26 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S3) , e106579
Open AccessBehavioral and Psychological Symptoms of Dementia as a Clinical Indicator of Disease Severity and Memory Decline in African Populations: Data from the READD–ADSP Project
Background: BPSD are common in persons living with dementia and are often associated with disease severity and caregivers’ distress. In Low‐ and Middle‐Income Countries, they are often the symptom complex that compel family to seek medical help. However, the association of BPSD with dementia severity and specific cognitive domains is underexplored in African populations. This study aims to evaluate BPSD among indigenous Africans and the association with specific cognitive domains. Method: This cross‐sectional study analyzes data collected from nine African countries (Nigeria, Benin, Ghana, Cameroon, Ethiopia, Kenya, Uganda, Tanzania, and Mozambique) participating in the Recruitment and Retention for Alzheimer's Disease Diversity Cohorts in the Alzheimer's Disease Sequencing Project (READD‐ADSP) project, from June 2023 to December 2024. Data on neurocognitive factors were collected using the Uniform Data Set (UDS), Neuropsychiatric Inventory Questionnaire (NPI‐Q) for BPSD, and the Clinical Dementia Rating (CDR) scale for dementia severity. Data was managed on REDCap and analysis was performed using STATA (v16). Descriptive statistics were employed for symptom prevalence, and Spearman's rank correlation was used to analyze the relationship between NPI‐Q and CDR scores. Association between cognitive domains and behavioral symptoms was examined using hierarchical linear model adjusting for covariates such as age, gender, education, and illness duration. Result: A total of 641 Africans with dementia (61% female, mean age 76.7±10.1 years) were included. The mean (±SD) NPI and CDR scores were 4.91 (±6.25) and 1.84 (±1.25), respectively. The most prevalent BPSD symptoms were apathy (32%), agitation/aggression (28.7%), and depression (28.1%). Spearman's correlation revealed a weak but significant positive association between NPI‐Q severity scores and CDR scores (rho = 0.264, p < 0.001). Behavioral symptoms were significantly associated with dementia severity (β = 1.59, CI: 1.15–2.03) as well as specific cognitive domains, particularly memory (digit span backward: β = ‐0.38, CI: ‐0.64 to ‐0.13). However, the duration of illness was not a significant predictor of behavioral symptoms in this cohort. Conclusion: The findings suggest that BPSD are both an indicator and consequence of dementia severity, particularly in memory function. This study posits the need for targeted management of BPSD and improvement in overall patient care in LMICs